InsidersTradesSigma
Follow the Veloxis Pharmaceuticals A/S stock price and the full management transaction log of the company, a publicly traded company based in Denmark. Shares are listed on the DK market, under the oversight of Finanstilsynet DK. Operating in the Health Care sector, Veloxis Pharmaceuticals A/S has published 15 reports. The latest transaction was reported on 15 January 2020 (Other). Every trade is openly available.
15
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 15 January 2020
Declarations15 total
ShareDK:918081
ShareISIN DK0060048148DK:395287
ShareISIN DK0060048148DK:394213
ShareISIN DK0060048148DK:315552
ShareISIN DK0060048148DK:315293
ShareISIN DK0060048148DK:288637
ShareISIN DK0060131043DK:268028
ShareISIN DK0060048148DK:266963
ShareISIN DK0060048148DK:265184
ShareISIN DK0060048148DK:264629
ShareISIN DK0060048148DK:250395
ShareISIN DK0060048148DK:236074
ShareISIN DK0060048148DK:235863
ShareISIN DK0060048148DK:221490
ShareISIN DK0060048148DK:166905
15 of 15 declarations
About Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S is a pharmaceutical company focused on developing medications for transplant patients. It aims to improve immunosuppressive treatments.